HBIO
NASDAQ
$6.11
Harvard Bioscience Inc (HBIO)
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enable fundamental research, discovery, and preclinical testing for drug development. The company is headquartered in Holliston, Massachusetts.
Sector:
Healthcare
Industry:
Medical Instruments & Supplies
Buy
Target: $6 (-1.80%)
Market Cap
$27M
Free Cash Flow Yield
7.02%
Beta (5Y)
2.12
Price Chart
Valuation
Market Cap$27M
Forward P/E15.06
PEG1.31
P/S0.32
P/B2.65
Profitability
Total Revenue (TTM)$86M
Gross Profit (TTM)$50M
EBITDA$1.65M
Profit Margin-16.5%
Operating Margin-5.7%
EPS-$2.18
Financial Health
Debt-to-Equity360.5%
Free Cash Flow Yield7.02%
Growth & Risk
EPS 5Y CAGR+16.59%
Revenue 5Y CAGR-4.08%
FCF 5Y CAGR-21.57%
Beta (5Y)2.12
Sharpe Ratio0.73